Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) — Cash Flow-to-Debt Ratio
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of TL-3.02 Million could theoretically repay 0% of its total liabilities (TL468.13 Million) in one year. See ANGEN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret across 7 annual periods. Also explore ANGEN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2018–2024)
Year-by-year debt coverage analysis for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. For market capitalisation and broader financial context, see Anatolia Tani ve Biyoteknoloji Urunleri market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.60x | TL141.41 Million | TL235.37 Million | ▼ -71.4% |
| 2023 | 2.10x | TL424.36 Million | TL201.96 Million | ▼ -72.6% |
| 2022 | 7.68x | TL311.02 Million | TL40.51 Million | ▼ -35.9% |
| 2021 | 11.98x | TL407.20 Million | TL33.98 Million | ▲ +204.0% |
| 2020 | 3.94x | TL235.47 Million | TL59.74 Million | ▲ +894.0% |
| 2019 | 0.40x | TL6.69 Million | TL16.86 Million | ▲ +28.5% |
| 2018 | 0.31x | TL3.16 Million | TL10.24 Million | — |